Anigen Signs Contract for Production of Active Pharmaceutical Ingredients and Supply of Goods Worth 1.9 Billion KRW
[Asia Economy Reporter Minji Lee] Anigen announced on the 20th that it has signed a contract with Cellivery for the production of active pharmaceutical ingredients and supply of goods. The contract amount is approximately 1.9 billion KRW, which accounts for 30% of recent sales revenue.
Hot Picks Today
Taking Annual Leave and Adding "Strike" to Profiles, "It Feels Like Samsung Has Collapsed"... Unsettled Internal Atmosphere
- There Is a Distinct Age When Physical Abilities Decline Rapidly... From What Age Do Strength and Endurance Drop?
- "One Comment Could Lead to a Report": 86% of Elementary Teachers Feel Anxious; Half Consider Resignation or Career Change
- "After Vowing to Become No. 1 Globally, Sudden Policy Brake Puts Companies’ Massive Investments at Risk"
- On Teacher's Day, a Student's Gifted Cake Had to Be Cut into 32 Pieces... Why?
This content was produced with the assistance of AI translation services.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
